Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.27M | $ 23.28M | $ 64.45M | $ 49.57M | $ 12.07M |
| Gross Profit | $ 1.27M | $ -13.48M | $ 64.45M | $ -23.52M | $ 12.07M |
| Operating Income | $ -176.10M | $ -27.06M | $ -33.50M | $ -42.26M | $ -71.85M |
| EBITDA | $ -175.87M | $ -26.95M | $ -33.36M | $ -42.07M | $ -70.80M |
| Net Income | $ -169.83M | $ -22.93M | $ -33.58M | $ -42.47M | $ -72.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 189.82M | $ 35.78M | $ 32.73M | $ 62.27M | $ 35.91M |
| Total Assets | $ 214.80M | $ 67.03M | $ 47.49M | $ 75.33M | $ 60.42M |
| Total Debt | $ 3.58M | $ 4.88M | $ 1.21M | $ 5.06M | $ 7.96M |
| Net Debt | $ -186.25M | $ -30.90M | $ -31.52M | $ -57.21M | $ -27.95M |
| Total Liabilities | $ 51.49M | $ 75.24M | $ 61.92M | $ 53.75M | $ 49.71M |
| Stockholders' Equity | $ 163.31M | $ -8.21M | $ -14.44M | $ 21.57M | $ 10.71M |
| Cash Flow | |||||
| Free Cash Flow | $ -176.66M | $ -22.94M | $ -28.59M | $ -25.27M | $ -54.60M |
| Operating Cash Flow | $ -176.53M | $ -22.43M | $ -28.47M | $ -25.23M | $ -54.41M |
| Investing Cash Flow | $ -129.00K | $ -505.00K | $ -118.00K | $ -41.00K | $ -186.00K |
| Financing Cash Flow | $ 337.06M | $ 25.98M | $ -951.00K | $ 44.60M | $ 37.28M |